Eptotermin alfa - Olympus Biotech

Drug Profile

Eptotermin alfa - Olympus Biotech

Alternative Names: Opgenra; Osigraft

Latest Information Update: 07 Aug 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Olympus Biotech Europe SAS
  • Class Bone morphogenetic proteins; Calcium regulators; Osteoporosis therapies; Recombinant proteins
  • Mechanism of Action Apoptosis inhibitors; Collagen stimulants; Matrix metalloproteinase 13 modulators; Proteoglycan stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Non-union fracture; Spondylolisthesis

Most Recent Events

No Data Available
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top